JC
LSTA icon

JBF Capital’s Lisata Therapeutics LSTA Stock Holding History

JBF Capital’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.8K Buy
14,347
+1,113
+8% +$3.96K 0.01% 97
2026
Q1 		$66.3K Buy
+13,234
New +$54.6K 0.01% 108

Other funds holding LSTA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
GS
GTS Securities Miami, Florida $4.75B AUM 41.97% 1-Year Est. Return

JBF Capital's LSTA Position: Q2 2026 in Review

JBF Capital increased its Lisata Therapeutics (LSTA) stake by 8.4% in Q2 2026, buying an estimated $3.96K and bringing the position to 14,347 shares worth $48.8K. The position accounts for 0.01% of the portfolio, ranked #97.

JBF Capital first reported a position in LSTA in Q1 2026 and has held it in 2 quarters since. The position peaked at $66.3K in Q1 2026. 31 funds tracked by Wall St. Rank hold LSTA as of Q2 2026.

  • JBF Capital held 14,347 shares of Lisata Therapeutics worth $48.8K as of Q2 2026.
  • JBF Capital bought 1,113 Lisata Therapeutics shares in Q2 2026, an estimated $3.96K.
  • Lisata Therapeutics made up 0.01% of JBF Capital's portfolio in Q2 2026, its #97 holding.
  • JBF Capital first reported a position in Lisata Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • JBF Capital's Lisata Therapeutics position peaked at $66.3K in Q1 2026.
  • 31 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2026.

Based on JBF Capital's 13F filing for Q2 2026, filed 13 Aug 2026.